BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• 

  Policy

  FDA Berates Bayer for Inadequate Cleaning, QC Questions at HQ

  The company is addressing the FDA’s complaints regarding manufacturing practices, which stem from a routine inspection in January,

  February 14, 2018

   · 

  1 min read
• 

  Genetown

  3 Biotechs Facing Stiff Headwinds in 2018

  The stock market has been rocky recently, but overall the biotech market appears to have been comparatively stable.

  February 14, 2018

   · 

  3 min read

   · 

  Mark Terry
• 

  Meet the Little-Known Chinese CAR-T Biotech Up More Than 500% Since June 2017

  The company reported positive results from early studies in 35 patients with a type of blood cancer last year.

  February 14, 2018

   · 

  2 min read

   · 

  Alex Keown
• 

  Policy

  Merck Chemist Arrested for Stealing Deadly Chemical

  The 60-year-old chemist has been charged with stealing 219.79 grams of potassium cyanide from a Merck facility in Pennsylvania.

  February 14, 2018

   · 

  2 min read

   · 

  Alex Keown
• Deals

  Harbin Pharma to Acquire 40% of US-based GNC for $300M

  Hayao will also form a JV with GNC to make and distribute GNC supplements in China.

  February 14, 2018

   · 

  1 min read
• 

  Business

  Go Big or Go Home: Bristol-Myers Bets $3.6B on Nektar’s Early-Stage Cancer Prospect

  Rumors of Nektar Therapeutics being up for sale may have been premature.

  February 14, 2018

   · 

  3 min read

   · 

  Alex Keown
• 

  Business

  Jobs Affected as ImmunoGen Winds Down Ops at Massachusetts Facility

  ImmunoGen gave a pipeline progress report and 2017 operating results last week.

  February 14, 2018

   · 

  2 min read

   · 

  Mark Terry
• 

  FDA

  J&J Wins FDA Nod for Erleada, the First Drug for Nonmetastatic Prostate Cancer

  Janssen got a little love from the FDA on Wednesday.

  February 14, 2018

   · 

  3 min read

   · 

  Alex Keown
• BioCapital

  Xtant Medical Announces Results of Special Meeting of Stockholders

  As a result of the approval of all proposals at the Special Meeting, Xtant expects that it will be able to fully execute its previously announced restructuring plan.

  February 14, 2018

   · 

  12 min read
• Business

  ImmunoQure AG and Servier Enter Into Strategic Partnership for the Development of an Interferon-Alpha Human Autoantibody

  ImmunoQure and Servier will work collaboratively to advance ImmunoQure’s therapeutic human Interferon-alpha autoantibody through preclinical development and into the clinic.

  February 14, 2018

   · 

  4 min read